Amgen Inc. (BCBA:AMGN)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of ARS 202.54 trillion. The enterprise value is 265.08 trillion.

Market Cap	202.54T
Enterprise Value	265.08T

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	May 16, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.32M

Valuation Ratios

The trailing PE ratio is 31.81 and the forward PE ratio is 14.14.

PE Ratio	31.81
Forward PE	14.14
PS Ratio	5.53
PB Ratio	30.41
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.92, with an EV/FCF ratio of 22.63.

EV / Earnings	41.64
EV / Sales	6.03
EV / EBITDA	12.92
EV / EBIT	20.05
EV / FCF	22.63

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 9.24.

Current Ratio	1.17
Quick Ratio	0.74
Debt / Equity	9.24
Debt / EBITDA	3.60
Debt / FCF	5.26
Interest Coverage	2.88

Financial Efficiency

Return on equity (ROE) is 105.67% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE)	105.67%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	9.67%
Return on Capital Employed (ROCE)	15.47%
Revenue Per Employee	1.31B
Profits Per Employee	227.38M
Employee Count	28,000
Asset Turnover	0.37
Inventory Turnover	1.37

Taxes

In the past 12 months, Amgen has paid 769.41 billion in taxes.

Income Tax	769.41B
Effective Tax Rate	10.78%

Stock Price Statistics

The stock price has decreased by -21.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.33%
50-Day Moving Average	11,331.50
200-Day Moving Average	11,698.40
Relative Strength Index (RSI)	60.62
Average Volume (20 Days)	3,124

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.38

Income Statement

In the last 12 months, Amgen had revenue of ARS 36.62 trillion and earned 6.37 trillion in profits. Earnings per share was 11,742.69.

Revenue	36.62T
Gross Profit	25.29T
Operating Income	11.02T
Pretax Income	7.14T
Net Income	6.37T
EBITDA	16.88T
EBIT	11.02T
Earnings Per Share (EPS)	11,742.69

Balance Sheet

The company has 9.45 trillion in cash and 61.58 trillion in debt, giving a net cash position of -52,121.54 billion.

Cash & Cash Equivalents	9.45T
Total Debt	61.58T
Net Cash	-52,121.54B
Net Cash Per Share	n/a
Equity (Book Value)	6.66T
Book Value Per Share	12,387.45
Working Capital	4.21T

Cash Flow

In the last 12 months, operating cash flow was 13.08 trillion and capital expenditures -1,370.35 billion, giving a free cash flow of 11.71 trillion.

Operating Cash Flow	13.08T
Capital Expenditures	-1,370.35B
Free Cash Flow	11.71T
FCF Per Share	n/a

Margins

Gross margin is 69.07%, with operating and profit margins of 30.08% and 17.39%.

Gross Margin	69.07%
Operating Margin	30.08%
Pretax Margin	19.49%
Profit Margin	17.39%
EBITDA Margin	46.08%
EBIT Margin	30.08%
FCF Margin	31.98%

Dividends & Yields

This stock pays an annual dividend of 207.33, which amounts to a dividend yield of 1.62%.

Dividend Per Share	207.33
Dividend Yield	1.62%
Dividend Growth (YoY)	78.53%
Years of Dividend Growth	14
Payout Ratio	82.64%
Buyback Yield	-0.88%
Shareholder Yield	0.74%
Earnings Yield	3.14%
FCF Yield	5.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 3.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	3

Scores

Amgen has an Altman Z-Score of 1.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	6